In Vivo Antihyperlipidemic Activity of TD.HLM01 – A Vietnamese Traditional Remedy in Experimental Models
Tung Thanh Tran(1), Ha Thi Thu Nguyen(2), Thuy Thanh Nguyen(3), Lien Huong Thi Nguyen(4), Van Hong Thi Nguyen(5), Hang Thi Thuy Nguyen(6), Quang Vinh Trinh(7), Hang Thi Thu Dinh(8), Duong Thuy Dau(9), Phong Xuan Pham(10), Nghia Trong Duong(11), Van Anh Thi Pham(12*)
(1) Hanoi Medical University, Hanoi
(2) Hanoi Medical University, Hanoi
(3) Hanoi Medical University, Hanoi
(4) Sao Thai Duong Joint Stock Company, Hanoi
(5) Sao Thai Duong Joint Stock Company, Hanoi
(6) Hanoi Medical University, Hanoi
(7) Hanoi Medical University, Hanoi
(8) Hanoi Medical University, Hanoi
(9) Hanoi Medical University, Hanoi
(10) Military Institute of Traditional Medicine, Hanoi
(11) National Hospital of Traditional Medicine, Hanoi
(12) Hanoi Medical University, Hanoi
(*) Corresponding Author
Abstract
One of the primary risk factors for cardiovascular disease nowadays is dyslipidemia. For many years, multi-herbal preparations have been the standard treatment approach for treating dyslipidemia. The purpose of this study was to assess the effects of TD.HLM01 hard capsule on experimental rodent models of endogenous and exogenous dyslipidemia. To create hyperlipidemia in the endogenous hyperlipidemia paradigm, mice were first given TD.HLM01 hard capsule therapy and intraperitoneal injections of poloxamer-407. In the exogenous model, rats were given a diet of oil-cholesterol mixture orally and treated with TD.HLM01 hard capsules for four consecutive weeks. Serum lipid parameters were evaluated in both experiments. The results indicated that TD.HLM01 significantly reduced TC, TG, and non-HDL-C levels in the experimental models of exogenous hyperlipidemia and endogenous hyperlipidemia. TD.HLM01 improved the serum LDH levels and ameliorated the elevated AST and ALT levels in cholesterol-induced hyperlipidemia rats. This study has demonstrated the potential efficacy of TD.HLM01 in hyperlipidemia experimental models in vivo.
Keywords
Full Text:
PDFReferences
Adegbola, P., Aderibigbe, I., Hammed, W., & Omotayo, T. (2017). Antioxidant and anti-inflammatory medicinal plants have potential role in the treatment of cardiovascular disease: A review. American Journal of Cardiovascular Disease, 7(2), 19–32.
Alruhaimi, R. S., Hussein, O. E., Alnasser, S. M., Germoush, M., Alotaibi, M., Hassanein, E. H. M., Mohtadi, M. E., & Mahmoud, A. M. (2024). Oxidative Stress, Inflammation, and Altered Lymphocyte E-NTPDase Are Implicated in Acute Dyslipidemia in Rats: Protective Role of Arbutin. Pharmaceuticals, 17. https://doi.org/10.3390/ph17101343
Andreadou, I., Schulz, R., Badimon, L., Adameová, A., Kleinbongard, P., Lecour, S., Nikolaou, P., Falcão‐Pires, I., Vilahur, G., Woudberg, N., Heusch, G., & Ferdinandy, P. (2020). Hyperlipidaemia and cardioprotection: Animal models for translational studies. British Journal of Pharmacology, 177(23), 5287–5311. https://doi.org/10.1111/bph.14931
Arefhosseini, S., Tutunchi, H., Nomi-Golzar, S., Mahboob, S., Pouretedal, Z., & Ebrahimi-Mameghani, M. (2022). The effect of hydroxy citric acid supplementation with calorie-restricted diet on metabolic, atherogenic and inflammatory biomarkers in women with non-alcoholic fatty liver disease: A randomized controlled clinical trial. Food & Function, 13(9), 5124–5134. https://doi.org/10.1039/d1fo03685h
Ba Tuyen, P., Huyen, T. T., Hang, D. T. T., & Thi Van Anh, P. (2021). A Novel Herbal Medicine for Dyslipidemia: Assessments in Experimental Models. Evidence-Based Complementary and Alternative Medicine : eCAM, 2021, 5529744. https://doi.org/10.1155/2021/5529744
Bhattaram, V., Graefe, U., Kohlert, C., Veit, M., & Derendorf, H. (2002). Pharmacokinetics and bioavailability of herbal medicinal products. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology, 9 Suppl 3, 1–33. https://doi.org/10.1078/1433-187X-00210
Center for Drug Evaluation and Research (FDA). (2005). Guidance for Industry Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. Pharmacology and Toxicology.
Cunha, L. F., Ongaratto, M. A., Endres, M., & Barschak, A. G. (2021). Modelling hypercholesterolaemia in rats using high cholesterol diet. International Journal of Experimental Pathology, 102(2), 74–79. https://doi.org/10.1111/iep.12387
Davies, J. T., Delfino, S. F., Feinberg, C. E., Johnson, M. F., Nappi, V. L., Olinger, J. T., Schwab, A. P., & Swanson, H. I. (2016). Current and Emerging Uses of Statins in Clinical Therapeutics: A Review. Lipid Insights, 9, 13–29. https://doi.org/10.4137/LPI.S37450
Engelking, L. J., McFarlane, M., Li, C., & Liang, G. (2012). Blockade of cholesterol absorption by ezetimibe reveals a complex homeostatic network in enterocytes[S]. Journal of Lipid Research, 53, 1359–1368. https://doi.org/10.1194/jlr.M027599
Feng, S., Dai, Z., Liu, A. B., Huang, J., Narsipur, N., Guo, G., Kong, B., Reuhl, K., Lu, W., Luo, Z., & Yang, C. S. (2018). Intake of stigmasterol and β-sitosterol alters lipid metabolism and alleviates NAFLD in mice fed a high-fat western-style diet. Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids, 1863(10), 1274–1284. https://doi.org/10.1016/j.bbalip.2018.08.004
Gao, Y., Xin, D., Liang, X.-D., & Tang, Y. (2023). Effect of a combination of Atractylodes macrocephala extract with strychnine on the TLR4/NF-κB/NLRP3 pathway in MH7A cells. Experimental and Therapeutic Medicine, 25(2), 91. https://doi.org/10.3892/etm.2023.11791
Gesto, D., Pereira, C. M. S., Cerqueira, N., & Sousa, S. (2020). An Atomic-Level Perspective of HMG-CoA-Reductase: The Target Enzyme to Treat Hypercholesterolemia. Molecules, 25. https://doi.org/10.3390/molecules25173891
Gogoi, A., Gogoi, N., & Neog, B. (2015). Dubious anti-obesity agent HCA from garcinia: A systematic review. International Journal of Pharmacy and Pharmaceutical Sciences, 7.
Itodo, M. (2023). Antilipidemic Potentials of Moringa Oleifera Root Extract in Poloxamer 407- Induced Hyperlipidemia. https://doi.org/10.5281/zenodo.10438987
Korolenko, T. A., Johnston, T. P., Tuzikov, F. V., Tuzikova, N. A., Pupyshev, A. B., Spiridonov, V. K., Goncharova, N. V., Maiborodin, I. V., & Zhukova, N. A. (2016). Early-stage atherosclerosis in poloxamer 407-induced hyperlipidemic mice: Pathological features and changes in the lipid composition of serum lipoprotein fractions and subfractions. Lipids in Health and Disease, 15(1), 16. https://doi.org/10.1186/s12944-016-0186-7
Li, B., Jiang, X.-F., Dong, Y.-J., Zhang, Y.-P., He, X.-L.-S., Zhou, C.-L., Ding, Y.-Y., Wang, N., Wang, Y.-B., Cheng, W.-Q., Jiang, N.-H., Su, J., Lv, G.-Y., & Chen, S.-H. (2024). The effects of Atractylodes macrocephala extract BZEP self-microemulsion based on gut–liver axis HDL/LPS signaling pathway to ameliorate metabolic dysfunction-associated fatty liver disease in rats. Biomedicine & Pharmacotherapy, 175, 116519. https://doi.org/10.1016/j.biopha.2024.116519
Mohan, S. K., Veeraraghavan, V. P., & Jainu, M. (2015). Effect of pioglitazone, quercetin and hydroxy citric acid on extracellular matrix components in experimentally induced non-alcoholic steatohepatitis. Iranian Journal of Basic Medical Sciences, 18(8), 832–836.
Nguyen, T. H., Ly, H. H. V., Nguyen, T. M., Diem Le, T. T., Phung, T. M., Nejatbakhsh, R., Nguyen, K. T., & Tran, T. T. T. (2023). The effects of Glycyrrhiza Glabra extract in high-fat diet-induced obese male mice: A controlled experimental study. Obesity Medicine, 44, 100525. https://doi.org/10.1016/j.obmed.2023.100525
Rader, D. J., & Kathiresan, S. (2018). Disorders of Lipoprotein Metabolism. In J. L. Jameson, A. S. Fauci, D. L. Kasper, S. L. Hauser, D. L. Longo, & J. Loscalzo (Eds.), Harrison’s Principles of Internal Medicine (20th ed.). McGraw-Hill Education. accessmedicine.mhmedical.com/content.aspx?aid=1183992782
Rajesh, O., & Patil, V. (2024). Review Article on Animal Models in Preclinical Research in Hyperlipidemia. International Journal of Pharmaceutical Sciences Review and Research, 84, 71–75. https://doi.org/10.47583/ijpsrr.2024.v84i01.011
Semwal, R., Semwal, D., Vermaak, I., & Viljoen, A. (2015). A comprehensive scientific overview of Garcinia cambogia. Fitoterapia, 102, 134–148. https://doi.org/10.1016/j.fitote.2015.02.012
US Preventive Services Task Force. (2022). Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement. JAMA, 328(8), 746–753. https://doi.org/10.1001/jama.2022.13044
Vekic, J., Stromsnes, K., Mazzalai, S., Zeljkovic, A., Rizzo, M., & Gambini, J. (2023). Oxidative Stress, Atherogenic Dyslipidemia, and Cardiovascular Risk. Biomedicines, 11(11), Article 11. https://doi.org/10.3390/biomedicines11112897
Vietnamese Ministry of Health. (2017). Vietnamese Pharmacopeia (Fifth edition). Medical Publishing House Co., Ltd.
Wang, B., Huang, S., Li, S., Deng, Y., Li, Z., Wang, Y., Shi, X., Zhang, W., Shi, L., Wang, X., & Tang, X. (2025). Hepatotoxicity of statins: A real-world study based on the US Food and Drug Administration Adverse Event Reporting System database. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1502791
Wang, J.-H., Bose, S., Kim, H.-G., Han, K.-S., & Kim, H. (2015). Fermented Rhizoma Atractylodis Macrocephalae alleviates high fat diet-induced obesity in association with regulation of intestinal permeability and microbiota in rats. Scientific Reports, 5(1), 8391. https://doi.org/10.1038/srep08391
Wang, X.-X., Liu, G.-Y., Yang, Y.-F., Wu, X., Xu, W., & Yang, X. (2017). Intestinal Absorption of Triterpenoids and Flavonoids from Glycyrrhizae radix et rhizoma in the Human Caco-2 Monolayer Cell Model. Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry, 22. https://doi.org/10.3390/molecules22101627
Welz, A. N., Emberger-Klein, A., & Menrad, K. (2018). Why people use herbal medicine: Insights from a focus-group study in Germany. BMC Complementary and Alternative Medicine, 18(1), 92. https://doi.org/10.1186/s12906-018-2160-6
Witte, W. E. A., Danhof, M., Graaf, P., & Lange, E. D. (2018). The implications of target saturation for the use of drug–target residence time. Nature Reviews Drug Discovery, 18, 82–84. https://doi.org/10.1038/nrd.2018.234
Xiong, F., Liang, H.-X., Zhang, Z.-J., Mahmud, T., Chan, A. S. C., Li, X., & Lan, W.-J. (2021). Characterization, Antioxidant and Antitumor Activities of Oligosaccharides Isolated from Evodia lepta (Spreng) Merr. By Different Extraction Methods. Antioxidants, 10(11), 1842. https://doi.org/10.3390/antiox10111842
Xiong, H., Wang, J., Ran, Q., Lou, G., Peng, C., Gan, Q., Hu, J., Sun, J., Yao, R., & Huang, Q. (2019). Hesperidin: A Therapeutic Agent For Obesity. Drug Design, Development and Therapy, 13, 3855–3866. https://doi.org/10.2147/DDDT.S227499
Yang, L., Qin, S.-H., & Zi, C.-T. (2024). Research progress of Gastrodia elata Blume polysaccharides: A review of chemical structures and biological activities. Frontiers in Chemistry, 12, 1395222. https://doi.org/10.3389/fchem.2024.1395222
Yang, S.-H., Zhu, J., Wu, W.-T., Li, J.-M., Tong, H.-L., Huang, Y., Gong, Q.-F., Gong, F.-P., & Zhong, L.-Y. (2023). Rhizoma Atractylodis Macrocephalae—Assessing the influence of herbal processing methods and improved effects on functional dyspepsia. Frontiers in Pharmacology, 14, 1236656. https://doi.org/10.3389/fphar.2023.1236656
Yu, J.-J., Su, J., Yan, M.-Q., Lou, Z.-H., & Lyu, G.-Y. (2019). [Correlation between lipid-lowering efficacy and components of Pericarpium Citri Reticulatae]. Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica, 44(15), 3335–3342. https://doi.org/10.19540/j.cnki.cjcmm.20190523.304
Zhu, W., Ma, Y., Guo, W., Lu, J., Li, X., Wu, J., Qin, P., Zhu, C., & Zhang, Q. (2022). Serum Level of Lactate Dehydrogenase is Associated with Cardiovascular Disease Risk as Determined by the Framingham Risk Score and Arterial Stiffness in a Health-Examined Population in China. International Journal of General Medicine, 15, 11–17. https://doi.org/10.2147/IJGM.S337517
Zou, J., Wang, J., Ye, W., Lu, J., Li, C., Zhang, D., Ye, W., Xu, S., Chen, C., Liu, P., & Liu, Z. (2022). Citri Reticulatae Pericarpium (Chenpi): A multi-efficacy pericarp in treating cardiovascular diseases. Biomedicine & Pharmacotherapy, 154, 113626. https://doi.org/10.1016/j.biopha.2022.113626
Article Metrics
Refbacks
- There are currently no refbacks.
Copyright (c) 2025 Majalah Obat Tradisional

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Faculty of Pharmacy
Universitas Gadjah Mada
.png)
.png)



